S&P 500 Boosts Lululemon; Pfizer Lowers Profits, Revenue Outlook
- October 13th, 2023
- 715 views
Lululemon Athletica Inc. (Nasdaq: LULU), a notable athletic apparel company, will replace Activision Blizzard Inc. (Nasdaq: ATVI) in the S&P 500 index, effective at the opening of trading on Wednesday, October 18.
The S&P 500 is widely recognized as a benchmark for the U.S. stock market, comprising 500 leading companies with significant market capitalization. As a constituent of the S&P 500, Lululemon Athletica will represent its industry among other major sectors.
$LULU was trading at $395.88 in after-hours, up $18.18 (4.81%) following the announcement.
In other news, Pfizer Inc. (NYSE: PFE) is revising its guidance. Solely from its COVID products, the pharmaceutical giant now expects its full-year 2023 revenues to fall between $58.0 billion and $61.0 billion, down from the prior guidance range of $67.0 billion to $70.0 billion. As a result, Pfizer now expects adjusted diluted earnings per share (EPS) to range from $1.45 to $1.65, compared to the initial EPS range of $3.25 to $3.45 for the period
In after-hours, $PFE was trading at $31.03, down $1.08 (-3.36%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
NJCP National Football Conference Names David Dalton Head Coach of Salt Lake Yeti
February 06th, 2026FDA Takes New Approach to "No Artificial Colors" Claims
February 06th, 2026NJCP National Football Conference Announces Micah Deckart as Head Coach of the Idaho Outlaws
February 05th, 2026
Member Login